Vimarsana
Biggest News Aggregation in the World

Page 35 - Clinical Practice News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Clinical Practice. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Clinical Practice Today - Breaking & Trending Today

Data Presented at UEG Week 2023 Further Support the Potential of Celltrion's Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease - Vimarsana News

Data Presented at UEG Week 2023 Further Support the Potential of Celltrion's Investigational Subcutaneous Infliximab CT-P13 SC in the Treatment of Inflammatory Bowel Disease

Published: October 17, 2023

The latest clinical trial data for subcutaneous (SC) infliximab (CT-P13 SC), presented at the United European Gastroenterology (UEG) Week 2023 in Copenhagen, further support the potential of CT-P13 SC in patients with inflammatory bowel disease (IBD).LIBERTY-CD and LIBERTY-UC are registrational studies in patients w...

Source: pharmiweb.com
Related Topics:
United StatesNew JerseyStephenb HanauerTom NusbickelCelltrion IncDrug AdministrationEuropean CommissionDigestive Health Center At Northwestern MedicineEuropean Medicines AgencyFeinberg School Of MedicineUnited European GastroenterologyCelltrion HealthcareBiologics License ApplicationDigestive Health CenterNorthwestern MedicineFeinberg SchoolChief Commercial OfficerCelltrion United StatesGood Manufacturing PracticeProduct CharacteristicsSubcutaneous InfliximabInflammatory Bowel DiseaseClinical PracticeFull Year
Federal task force to weigh mammogram screening age amid debate over starting at 40 - Vimarsana News

Federal task force to weigh mammogram screening age amid debate over starting at 40

Published: October 17, 2023

Other experts point to data that suggests lowering the screening age may not improve outcomes

Source: theglobeandmail.com
Related Topics:
New HampshireUnited StatesMartin YaffeMichael PollakSteven WoloshinDartmouth Institute For HealthMcgill UniversityUs Preventive Services TaskCanadian Task Force On Preventive Health CareSunnybrook Health Sciences CentreServices Task ForceLog Increate FreeCanadian Task ForcePreventive Health CareJewish General HospitalNew England JournalDartmouth InstituteHealth PolicyClinical PracticeUs Preventive Services Task ForceNew England Journal Of Medicine
The Transformative Potential of Multicancer Early Detection Testing - Vimarsana News

The Transformative Potential of Multicancer Early Detection Testing

Published: October 17, 2023

Expert panelists delve into multicancer early detection testing and discuss its potential to revolutionize cancer screening, close healthcare gaps, and complement standard care approaches.

Source: onclive.com
Related Topics:
Emerging StrategiesMulti Cancer Early DetectionTransformative PotentialMulticancer Early DetectionMced TestsMolecular Cancer DiagnosticsTumor BiologyCell Free DnaCirculating Tumor DnaPrognostic MarkerDiagnostic TestingStandard Of Care ScreeningHealthcare GapsCurative InterventionFalse Positive ResultsBlood Based TestingClinical Practice
Free flu clinic, KBIC receives transformational bequest: Seacoast health news - Vimarsana News

Free flu clinic, KBIC receives transformational bequest: Seacoast health news

Published: October 12, 2023

A roundup of news from the Seacoast health care community.

Source: yahoo.com
Related Topics:
United StatesKennebunk High SchoolSouth BerwickNew HampshireMarshwood High SchoolYork HospitalYork CountyThomas Jefferson UniversityCamden Cami WebberJonathand LichtensteinRuth CarrollSteve WadeKate FordAva SmithJo LampreyMichaelc RossiterYork Hospital Scholarship CommitteeBrain Injury Association Of New HampshireDartmouth HealthPediatric Associates Of York HospitalStudent CouncilPartners For World HealthSanford Regional Technical Center Health OccupationsAnimal Welfare SocietyYearbook Club
Bristol Myers Squibb to Showcase Data Demonstrating Improved Outcomes in Earlier Stages of Cancer, Durable Long-Term Benefits with Opdivo-Based Regimens, and Addressing High Unmet Needs in Multiple Tumor Types at ESMO 2023 - Vimarsana News

Bristol Myers Squibb to Showcase Data Demonstrating Improved Outcomes in Earlier Stages of Cancer, Durable Long-Term Benefits with Opdivo-Based Regimens, and Addressing High Unmet Needs in Multiple Tumor Types at ESMO 2023

Published: October 12, 2023

First presentation of results from CheckMate -901 show survival benefit with Opdivo + chemotherapy in the first-line treatment of patients with unresectable or metastatic urothelial carcinoma who...

Source: marketscreener.com
Related Topics:
United StatesSouth KoreaJonas KuonVivek NarayanSamit HirawatMaria Vieito VillarRobert VerhoevenSherene LoiTom GeldartKlaus PantelBoris KubuschokBristol Myers SquibbKosei HasegawaChristophe Le TourneauMark AwadSumanta PalEvan LipsonEric BaudinTina CasconeIsabelle BorgetPaolo AsciertoPeter MohrRaymond HuangBob LiHossein Borghaei